UPDATE: Oncolytics Biotech (ONCY) Commences Dosing in KEYTRUDA + REOLYSIN Phase 1b
Tweet Send to a Friend
(Updated - January 19, 2016 6:40 AM EST)
Oncolytics Biotech Inc. (NASDAQ: ONCY) announced that the first patients have ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oncolytics Biotech Inc. (NASDAQ: ONCY) announced that the first patients have ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
